GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (OTCPK:MBXBF) » Definitions » Cyclically Adjusted Revenue per Share

MBXBF (Microbix Biosystems) Cyclically Adjusted Revenue per Share : $0.11 (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Microbix Biosystems Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Microbix Biosystems's adjusted revenue per share for the three months ended in Dec. 2024 was $0.031. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.11 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Microbix Biosystems's average Cyclically Adjusted Revenue Growth Rate was 7.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 3.60% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 2.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Microbix Biosystems was 6.30% per year. The lowest was 2.50% per year. And the median was 3.20% per year.

As of today (2025-05-18), Microbix Biosystems's current stock price is $0.25. Microbix Biosystems's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was $0.11. Microbix Biosystems's Cyclically Adjusted PS Ratio of today is 2.27.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Microbix Biosystems was 6.46. The lowest was 1.38. And the median was 2.50.


Microbix Biosystems Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Microbix Biosystems's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbix Biosystems Cyclically Adjusted Revenue per Share Chart

Microbix Biosystems Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.10 0.10 0.11 0.11

Microbix Biosystems Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.11 0.11 0.11 0.11

Competitive Comparison of Microbix Biosystems's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Microbix Biosystems's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microbix Biosystems's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Microbix Biosystems's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Microbix Biosystems's Cyclically Adjusted PS Ratio falls into.


;
;

Microbix Biosystems Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Microbix Biosystems's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.031/127.3637*127.3637
=0.031

Current CPI (Dec. 2024) = 127.3637.

Microbix Biosystems Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 0.023 99.789 0.029
201506 0.021 100.500 0.027
201509 0.022 100.421 0.028
201512 0.009 99.947 0.011
201603 0.024 101.054 0.030
201606 0.021 102.002 0.026
201609 0.031 101.765 0.039
201612 0.017 101.449 0.021
201703 0.023 102.634 0.029
201706 0.025 103.029 0.031
201709 0.027 103.345 0.033
201712 0.023 103.345 0.028
201803 0.024 105.004 0.029
201806 0.025 105.557 0.030
201809 0.028 105.636 0.034
201812 0.019 105.399 0.023
201903 0.033 106.979 0.039
201906 0.024 107.690 0.028
201909 0.028 107.611 0.033
201912 0.016 107.769 0.019
202003 0.020 107.927 0.024
202006 0.020 108.401 0.023
202009 0.019 108.164 0.022
202012 0.023 108.559 0.027
202103 0.026 110.298 0.030
202106 0.030 111.720 0.034
202109 0.022 112.905 0.025
202112 0.027 113.774 0.030
202203 0.027 117.646 0.029
202206 0.027 120.806 0.028
202209 0.023 120.648 0.024
202212 0.013 120.964 0.014
202303 0.021 122.702 0.022
202306 0.030 124.203 0.031
202309 0.023 125.230 0.023
202312 0.046 125.072 0.047
202403 0.030 126.258 0.030
202406 0.027 127.522 0.027
202409 0.034 127.285 0.034
202412 0.031 127.364 0.031

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Microbix Biosystems  (OTCPK:MBXBF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Microbix Biosystems's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.25/0.11
=2.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Microbix Biosystems was 6.46. The lowest was 1.38. And the median was 2.50.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Microbix Biosystems Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Microbix Biosystems's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Microbix Biosystems Business Description

Industry
Traded in Other Exchanges
Address
265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and; Development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.